MicroMarvel is a series of articles highlighting undercovered stock with less than a billion dollars in Market Capitalization. These articles are not intended to be buy recommendations. They highlight stocks that may have limited trading volume and may be highly volatile, so if you do decide to add them to your portfolio I highly recommend you use stop losses and limit orders.

Image Source: Pixabay

• 100% technical buy signals
• 14 new highs and up 95.45% in the last month
• 143.50+ Weighted Alpha

Today's MicroMarvel is the under-followed biotechnology company Neurogene (NGNE). I found the stock by using Barchart's screening functions to find stocks with the highest technical buy signals, highest Weighted Alpha, superior current momentum, and having a Trend Seeker buy signal, then used the Flipchart feature to review the charts for consistent price appreciation. Since the Trend Seeker signaled a buy on 12/22 the stock gained 95.45%.

NGNE Price vs Daily Moving Averages (Barchart)

Neurogene Inc. develops life-changing genetic medicines for patients and their families affected by neurological diseases. Its product candidate includes NGN-401, an investigational AAV9 gene therapy for the treatment of Rett syndrome; and NGN-101 to treat neuronal ceroid lipofuscinosis subtype 5 batten disease. The company is headquartered in New York, New York. 

Barchart's Opinion Trading systems are listed below as of time of writing.

Barchart Technical Indicators:

• 100% technical buy signals
• 143.50+ Weighted Alpha
• 161.15% gain in the last year
• Trend Seeker buy signal
• Above its 20, 50, and 100-day moving averages
• 14 new highs and up 95.45% in the last month
• Relative Strength Index 74.19%
• Technical support level at $28.83
• Recently traded at $30.10 with a 50-day moving average of $17.87

Fundamental Factors:

• Market Cap $71 million
• Wall Street is following this stock but has not given Revenue  projections
• They estimate Earnings will grow 73.20% this year, an additional 35.70% next year and continue to compound at an annual rate of 25.10% for the next 5 years

Analysts and Investor Sentiment -- I don't buy stocks because everyone else is buying but I do realize that if major firms and investors are dumping a stock it's hard to make money swimming against the tide:

• Wall Street analysts have 3 strong buy and 1 hold recommendation in place
• Their price targets are between $31 and $45 with a consensus of $38 for a 26% gain
• CFRAs MarketScope gives the stock a hold recommendation

More By This Author:

Chart Of The Day: Is Advanced Micro Devices Too Pricey?
MicroMarvel - Natural Health Trends
Chart Of The Day: Camtek - Another All Time High